功能性消化不良病理生理与治疗新概念:聚焦十二指肠
本文综述功能性消化不良(FD)病理生理与治疗的新进展,重点聚焦十二指肠。十二指肠黏膜屏障受损与低级别炎症与神经元信号改变及全身免疫激活相关,可能最终导致消化不良症状。诱导屏障缺陷的管腔候选因素包括酸、胆汁、微生物群和食物抗原,但尚未证实与症状的因果关系。
要点
- 十二指肠是FD病理生理的关键区域,参与胃十二指肠功能调控。
- 十二指肠黏膜屏障受损和低级别炎症与神经元信号改变及免疫激活相关。
- 酸、胆汁、微生物群和食物抗原可能诱导十二指肠屏障缺陷,但因果关系未证实。
核心结论
- 十二指肠病理生理参与FD症状发生,识别十二指肠病理有望发现新生物标志物和治疗靶点,实现基于生物学的靶向治疗而非仅对症治疗。
研究设计与样本
- 综述,总结FD诊断和治疗近期进展,重点聚焦十二指肠。
主要发现
- 十二指肠黏膜屏障受损和低级别炎症与神经元信号改变及全身免疫激活相关,可能最终导致消化不良症状。
- 诱导十二指肠屏障缺陷的管腔候选因素包括酸、胆汁、微生物群和食物抗原,但尚无令人信服的因果关联证据。
临床怎么用
- 关注十二指肠病理可能推动FD从基于症状的治疗转向基于生物学的靶向治疗。
局限性
- 管腔因素与症状的因果关系尚未被令人信服地证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Emerging data increasingly point towards the duodenum as a key region underlying the pathophysiology of functional dyspepsia (FD), one of the most prevalent functional GI disorders. The duodenum plays a major role in the control and coordination of gastroduodenal function. Impaired duodenal mucosal integrity and low-grade inflammation have been associated with altered neuronal signalling and systemic immune activation, and these alterations may ultimately lead to dyspeptic symptoms. Likely luminal candidates inducing the duodenal barrier defect include acid, bile, the microbiota and food antigens although no causal association with symptoms has been convincingly demonstrated. Recognition of duodenal pathology in FD will hopefully lead to the discovery of new biomarkers and therapeutic targets, allowing biologically targeted rather than symptom-based therapy. In this review, we summarise the recent advances in the diagnosis and treatment of FD with a focus on the duodenum.
引用
- Wauters L, Talley NJ, Walker MM, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut. 2019. PMID: 31784469. doi:10.1136/gutjnl-2019-318536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。